Revvity signals beyond the news: 18 signals from 3 sources
The latest Revvity signal on this page is from Sep 29, 2026 (Patents): "REVVITY HEALTH SCIENCES, INC. uses Seed Intellectual Property Law Group LLP as outside IP counsel." The busiest sources: Glassdoor (14), Patents (3) and Reddit (1).
PublicBiotechnology Research1,001 to 5,000 employeesrevvity.comLinkedIn
- Signals
- 18
- Sources
- 3
- Last 90 days
- 17
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Revvity signals by source
18 signals for Revvity across 3 sources.
Patents · Patent counsel
REVVITY HEALTH SCIENCES, INC. uses Seed Intellectual Property Law Group LLP as outside IP counsel.
Seed Intellectual Property Law Group LLP is the attorney of record on REVVITY HEALTH SCIENCES, INC.'s recent US patent work, including a grant in 2026-09.
- Law firm
- Seed Intellectual Property Law Group LLP
- Law firm domain
- seedip.com
- Matter date
- Sep 29, 2026
Patents · Patent grant
Revvity Health Sciences was granted a patent for multiplexed PCR automation.
In September 2026 Revvity Health Sciences patented a compact system for running multiplexed PCR tests in research and clinical laboratories.
- Patent title
- Multiplexed polymerase chain reaction in micropipette format
- Grant date
- Sep 29, 2026
- Inventors
- Andrew Brodsky
Patents · Patent pace
REVVITY HEALTH SCIENCES, INC.'s patent output is steady: 10 grants in the past year, 1 in the past 30 days.
Over the past year REVVITY HEALTH SCIENCES, INC. received 10 US patent grants; the recent pace (1 in 90 days) is steady versus its trailing baseline.
- Grants, 12 months
- 10
- Grants, 90 days
- 1
- Grants, 30 days
- 1
- USPTO assignee
- Revvity Health Sciences, Inc.
Glassdoor · Reorg chaos
Frequent and unexplained reorganizations cause stress and friction
One review mentions frequent reorganizations that are rarely explained, leading employees to speculate about their necessity and causing friction throughout the organization.
- Overall rating
- 3.7 of 5
- CEO approval
- 81%
- Reviews read
- 4
- Review window
- Sep 3, 2026 to Sep 8, 2026
Glassdoor · Growth opportunities
Employees cite lack of career progression and unclear promotion paths
Two reviews explicitly mention a lack of genuine career paths and difficulty seeing how to develop or progress within the company, with one noting it takes years for promotions and low raises.
- Overall rating
- 3.7 of 5
- CEO approval
- 81%
- Reviews read
- 4
- Review window
- Sep 3, 2026 to Sep 8, 2026
Glassdoor · Consistent leadership complaints
Senior management criticized for lack of accountability and poor communication
Multiple reviews describe senior management as a problem, citing lack of accountability, infrequent and unexplained reorganizations, and a disconnect between leadership and employees.
- Overall rating
- 3.7 of 5
- CEO approval
- 81%
- Reviews read
- 4
- Review window
- Sep 3, 2026 to Sep 8, 2026
Glassdoor · Compensation dissatisfaction
Multiple employees report underpaid salaries and poor benefits
Two reviewers mention low pay and dissatisfaction with benefits, with one specifically noting changes after the acquisition by Revvity led to higher deductibles and premiums.
- Overall rating
- 3.7 of 5
- CEO approval
- 81%
- Reviews read
- 4
- Review window
- Sep 3, 2026 to Sep 8, 2026
Glassdoor · Cross functional collaboration issues
Customs department manager lacks accountability causing employee stress and turnover
A specific customs department is described as a wreck, with the manager refusing accountability and providing no clear feedback, leading to overworked employees, stress, and a mass exodus.
- Overall rating
- 3.7 of 5
- CEO approval
- 81%
- Reviews read
- 4
- Review window
- Sep 3, 2026 to Sep 8, 2026
Reddit · Product change
Revvity has discontinued the free version of ChemSketch software following its recent acquisition of the original developer, ACD/Labs.
Post: "No more free ChemSketch"
- Subreddit
- r/Chempros
- Upvotes
- 90
- Comments
- 40
- Sentiment
- Negative
Glassdoor · Poor internal communication
Former employee cites terrible internal communication and lack of systems
A former client service representative stated that internal communication was terrible and advised management to set up better systems.
- Overall rating
- 3.7 of 5
- CEO approval
- 81%
- Reviews read
- 2
- Review window
- Jul 20, 2026 to Jul 23, 2026
Showing 10 of 18 signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Revvity with the Signal API
One POST /v1/companies/enrich call with revvity.com returns Revvity signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "revvity.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Revvity other signals
What signals does Autobound track for Revvity besides news and filings?
What are people saying about Revvity online?
What do employees say about working at Revvity?
Has Revvity been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .